Artwork

Content provided by American College of Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

51. Gout

50:29
 
Share
 

Manage episode 360360569 series 2681489
Content provided by American College of Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Gout, despite being one of the most well-known and recognizable rheumatic diseases, still has large populations of people struggling with its management, as they do not receive urate-lowering treatment, even when they qualify. Of those who receive this treatment, only a small percentage reach their target urate goal. To shed some light on this, we’ve invited Dr. Nicola Dalbeth, a Specialist Rheumatologist, who leads research on the mechanisms, impact and treatment of gout. Dr. Dalbeth is also a principal investigator of trials for novel therapeutic agents and treatment strategies in gout and in 2020, was also a member of the core oversight committee for the ACR Gout Management Guidelines. We discuss treatment efficacy, the disparities, myths and barriers to them, diagnosis, and strategies regarding management of gout.

  continue reading

91 episodes

Artwork

51. Gout

ACR on Air

17 subscribers

published

iconShare
 
Manage episode 360360569 series 2681489
Content provided by American College of Rheumatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Rheumatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Gout, despite being one of the most well-known and recognizable rheumatic diseases, still has large populations of people struggling with its management, as they do not receive urate-lowering treatment, even when they qualify. Of those who receive this treatment, only a small percentage reach their target urate goal. To shed some light on this, we’ve invited Dr. Nicola Dalbeth, a Specialist Rheumatologist, who leads research on the mechanisms, impact and treatment of gout. Dr. Dalbeth is also a principal investigator of trials for novel therapeutic agents and treatment strategies in gout and in 2020, was also a member of the core oversight committee for the ACR Gout Management Guidelines. We discuss treatment efficacy, the disparities, myths and barriers to them, diagnosis, and strategies regarding management of gout.

  continue reading

91 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide